Literature DB >> 31780423

Senescence in polyploid giant cancer cells: A road that leads to chemoresistance.

Deblina Bharadwaj1, Mahitosh Mandal2.   

Abstract

Cellular senescence has been associated with age-related diseases, wound healing, fibrosis, diabetes and cancer. Senescent cells lack the capacity to proliferate, but are known to aggravate tumorigenesis. The polyploid giant cells arise from the cancer cell population mainly due to genotoxic stress caused by chemotherapy and/or radiotherapy. They exhibit features of senescence and have been reported to secrete an array of cytokines, chemokines and growth factors. These small molecules can bind to their receptors located on the surface of neighboring cells and activate/deactivate relevant signaling pathways, thereby modulating the tumor microenvironment. Some of these signaling cascade(s) might play a role in imparting therapy resistance to the cancer cells. This review throws light on the incidence of senescence and how the senescent polyploid giant cells affect the tumor microenvironment. Their role in giving rise to chemoresistant cancer cell population as well as acquired chemoresistance in the neighboring cancer cells along with various potential and established therapeutic avenues have also been discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoresistance; Polyploid giant cells; Senescence; Senescence-associated secretory phenotype; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31780423     DOI: 10.1016/j.cytogfr.2019.11.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  15 in total

Review 1.  The life cycle of polyploid giant cancer cells and dormancy in cancer: Opportunities for novel therapeutic interventions.

Authors:  Jinsong Liu; Na Niu; Xiaoran Li; Xudong Zhang; Anil K Sood
Journal:  Semin Cancer Biol       Date:  2021-10-17       Impact factor: 15.707

2.  Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.

Authors:  Ryan C Hall; Nadia R Ayat; Peter L Qiao; Amita M Vaidya; Dan Ma; Anita Aminoshariae; Ivan Stojanov; Zheng-Rong Lu
Journal:  Mol Imaging Biol       Date:  2020-08-12       Impact factor: 3.488

Review 3.  Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.

Authors:  Geetanjali Saini; Shriya Joshi; Chakravarthy Garlapati; Hongxiao Li; Jun Kong; Jayashree Krishnamurthy; Michelle D Reid; Ritu Aneja
Journal:  Semin Cancer Biol       Date:  2021-03-22       Impact factor: 17.012

4.  "Mitotic Slippage" and Extranuclear DNA in Cancer Chemoresistance: A Focus on Telomeres.

Authors:  Kristine Salmina; Agnieszka Bojko; Inna Inashkina; Karolina Staniak; Magdalena Dudkowska; Petar Podlesniy; Felikss Rumnieks; Ninel M Vainshelbaum; Dace Pjanova; Ewa Sikora; Jekaterina Erenpreisa
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

5.  Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.

Authors:  K J Pienta; E U Hammarlund; J S Brown; S R Amend; R M Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 6.  The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.

Authors:  Quinn Storozynsky; Mary M Hitt
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 7.  Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.

Authors:  Ayushi Rai; Saba Noor; Syed Ishraque Ahmad; Mohamed F Alajmi; Afzal Hussain; Hashim Abbas; Gulam Mustafa Hasan
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

8.  Loss of Aurora Kinase Signaling Allows Lung Cancer Cells to Adopt Endoreplication and Form Polyploid Giant Cancer Cells That Resist Antimitotic Drugs.

Authors:  Vural Tagal; Michael G Roth
Journal:  Cancer Res       Date:  2020-11-10       Impact factor: 12.701

Review 9.  Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy.

Authors:  David Murray; Razmik Mirzayans
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

10.  The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.

Authors:  Xinyuan Ding; Yuting Gu; Min Jin; Xin Guo; Sudong Xue; Caihong Tan; Jiefang Huang; Wanlin Yang; Mingxing Xue; Qianjun Zhou; Wenjuan Wang; Yanyun Zhang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.